Skip to content
Generic selectors
Correspondance exacte uniquement
Recherche dans le titre
Rechercher dans le contenu
Post Type Selectors
ELA International
Secondary Navigation Menu
Menu
News
Archives News
Missions
Research funding
Support the families
To raise public awareness
International development
Organization
Our values
Our history
Our organization
ELA international’s members
The members
Advisory Board
Leukodystrophies
Introduction
Diseases
ALD/AMN
Undefined leukodystrophies
Canavan disease
Krabbe disease
Refsum disease
Alexander disease
MLC disease
MLD
PMD and other hypomyelinating leukodystrophies
Aicardi-Goutières syndrome
CACH syndrome
LTBL
The expert centers
Reference Center for Neurogenetic Diseases in Children and Adults
Reference Centre for Leukodystrophies in Robert-Debré
Reference Center for Leukodystrophies in Bicêtre
Make the expert centers known
Research
Scientific Committee
ELA Team
Main steps
Annual Call for Proposals
Clinical Trial FOA
Funded Research Projects
Clinical Studies
Leuconnect
Leuconnect
Studies online
Découvrez la messagerie de Leuconnect
Scientific events
Families/Researchers Meeting
Symposium
European Joint Programme on Rare Diseases (EJP Rare Diseases)
Additional documentation
Partners
Support
Become a donor
Mobilise
They support us
Become partner
Online shop
Contact
The only innovative treatment for CALD will not be available in Europe : the incomprehension of ELA International!
UK – Lutte contre les Leucodystrophies l’incomprehension d’ELA International
2022-11-08